Can COVID-19 Cause Mediastinal Lymphadenopathy?

Can COVID-19 Cause Mediastinal Lymphadenopathy
COVID-19 can cause mediastinal lymphadenopathy, but it is not considered a typical finding on chest CT scans of patients infected by COVID-19

COVID-19 can cause mediastinal lymphadenopathy, but it is not considered a typical finding on chest CT scans of patients infected by COVID-19.

A study published in The Lancet (November, 2020) showed the presence of mediastinal lymphadenopathy in critically ill patients with COVID-19. However, another review article (April, 2021) that analyzed multiple studies on mediastinal lymphadenopathy found that mediastinal lymphadenopathy was seen in around 0%-66% of COVID-19 cases. 

The condition was not significantly associated with any gender, age or age group, or cancer history and did not increase the need for noninvasive ventilation and ICU admission in patients with COVID-19. There was no difference in the length of hospital stay and pattern of lab results in patients with COVID-19 with and without mediastinal lymphadenopathy.

What is mediastinal lymphadenopathy?

Mediastinal lymphadenopathy refers to enlarged lymph nodes in the mediastinum, which is located between the lungs and contains all primary tissues and organs of the chest except the lungs:

  • Heart
  • Thymus gland
  • Portions of the esophagus and trachea
  • Cardiac nerves
  • Lymph nodes of the central chest

Lymph nodes are small bean-shaped structures that play a vital role in the body's immune system. They filter substances that travel through the lymphatic fluid and contain lymphocytes, which are white blood cells that help the body fight infection and disease.

What causes mediastinal lymphadenopathy?

Mediastinal lymphadenopathy generally indicates a problem with the lungs. The most common causes include

From a global perspective, mediastinal lymphadenopathy is primarily associated with tuberculosis given the high rate of infection (10 million per year). In the United States, it is most commonly associated with lung cancer and COPD.

How is mediastinal lymphadenopathy diagnosed?

Mediastinoscopy

Mediastinal lymphadenopathy can be detected in chest CT scans. To confirm the cause, mediastinoscopy with biopsy may be recommended. This is a minor surgical procedure that involves the insertion of a thin, flexible tube-like instrument (mediastinoscope) into the middle part of the chest to obtain a sample of one or multiple lymph nodes. The sample is then sent to a lab for examination under a microscope.

Fine needle aspiration cytology (FNAC)

Alternatively, a less invasive procedure called fine-needle aspiration cytology (FNAC) may be recommended. This involves the insertion of a long needle through the chest cavity into a lymph node to extract cells.

References
Image Source: iStock Images

Taweesedt PT, Surani S. Mediastinal lymphadenopathy in COVID-19: A review of literature. World J Clin Cases. 2021 Apr 26;9(12):2703-2710. https://pubmed.ncbi.nlm.nih.gov/33969053/

Iyer H, Anand A, Sryma PB, et al. Mediastinal lymphadenopathy: a practical approach. Expert Rev Respir Med. 2021 May 6;1-18. https://pubmed.ncbi.nlm.nih.gov/33888038/

McNally PA, Arthur ME. Mediastinoscopy. [Updated 2021 Sep 18]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2021 Jan. https://www.ncbi.nlm.nih.gov/books/NBK534863/

Valette X, du Cheyron D, Goursaud S. Mediastinal lymphadenopathy in patients with severe COVID-19. Lancet Infect Dis. 2020;20(11):1230. https://pubmed.ncbi.nlm.nih.gov/32330440/